Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Advances as Pfizer Drops Diabetes Deal
Bloomberg
Tuesday, March 13, 2012 - 11:05am
tags:
Novo Nordisk, Biocon, insulin, Pfizer, diabetes
Abbott Surging To $80, Shocking Naysayers
Seeking Alpha
Tuesday, March 13, 2012 - 11:04am
tags:
Abbott Laboratories, Merck, Pfizer, GeoVax Labs, Pharma-Bio Serv
Biocon Plunges After Ending Pfizer Insulin Distribution Pact
Bloomberg
Tuesday, March 13, 2012 - 11:03am
tags:
Pfizer, Biocon, insulin, diabetes
Arena Pharma's 5-Year Revenue Forecast
Seeking Alpha
Monday, March 12, 2012 - 8:44pm
tags:
Arena Pharmaceuticals
Vical's Allovectin: Why Hasn't The Trial Been Stopped?
Seeking Alpha
Monday, March 12, 2012 - 8:44pm
tags:
Vical, Allovectin, metastatic melanoma, melanoma, Zytiga, JNJ
Bristol-Myers CEO Gets 27% Pay Increase After Cancer Drug Sales Start Fast
Bloomberg
Monday, March 12, 2012 - 8:42pm
tags:
Bristol-Myers Squibb, Pharma CEOs, executive pay, Lamberto Andreotti
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk
Yahoo/AP
Monday, March 12, 2012 - 5:47pm
tags:
FDA, painkillers, Pfizer, JNJ, Regeneron, arthritis
J&J Said to Face Demand to Raise Risperdal Accord Offer by $800 Million
Bloomberg
Monday, March 12, 2012 - 5:45pm
tags:
JNJ, Risperdal
India licenses generic copy of patented Bayer drug
Yahoo/AP
Monday, March 12, 2012 - 5:45pm
tags:
Bayer, generics, India, liver cancer, kidney cancer, sorefinib, Natco
Keeping an Eye on Merck's Intangibles
Motley Fool
Monday, March 12, 2012 - 5:35pm
tags:
Merck
What Will Pfizer Do With its Animal Health Business?
Yahoo/Wall St Cheat Sheet
Monday, March 12, 2012 - 5:34pm
tags:
Pfizer, animal health
Pfizer, Social Media & Clinical Trials: Lipset Explains
Pharmalot
Monday, March 12, 2012 - 5:33pm
tags:
Pfizer, social media, clinical trials, overactive bladder, Detrol
Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit
Bloomberg
Monday, March 12, 2012 - 5:32pm
tags:
Teva Pharmaceuticals, Plan B contraceptive, One Step
Enzon Reports Fourth-Quarter and Full-Year 2011 Results
Yahoo
Monday, March 12, 2012 - 5:31pm
tags:
earnings, Enzon
Johnson & Johnson: A Solid Buy Candidate For 2012
Seeking Alpha
Monday, March 12, 2012 - 5:30pm
tags:
JNJ
Bio-Pharma Watch List: 2 Week Report Card
Seeking Alpha
Monday, March 12, 2012 - 5:30pm
tags:
Spectrum Pharmaceuticals, Acadia, Antares Pharma, BioSante, Indenix
BrainStorm Cell initiates study for MS
The Fly on the Wall
Monday, March 12, 2012 - 5:28pm
tags:
MS, multiple sclerosis, BrainStorm Cell Therapeutics, stem cells
Oncothyreon At $5: Buy Time Or Sign Of Trouble?
Seeking Alpha
Monday, March 12, 2012 - 10:43am
tags:
Oncothyreon
Ardea Posts Lower Revs, Wider Loss
Yahoo/Zacks
Monday, March 12, 2012 - 10:41am
tags:
earnings, Ardea
Pfizer Says Study Backs Use of Top Vaccine in Older Children
Bloomberg
Monday, March 12, 2012 - 10:28am
tags:
vaccines, Pfizer, Prevnar 13

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.